Research news

University College London Hospitals NHS Foundation Trust (UCLH) and Microsoft have announced a new strategic research and innovation collaboration to develop and apply advances in artificial intelligence (AI) and digital technologies for the future of healthcare delivery in the NHS.

A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.

In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.

The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.

UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.